- Home
- MDCX vs PPCB Comparison
MDCX vs PPCB Comparison
Compare MDCX & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- PPCB
- Stock Information
- Founded
- MDCX 2008
- PPCB 2007
- Country
- MDCX Canada
- PPCB Australia
- Employees
- MDCX N/A
- PPCB N/A
- Industry
- MDCX
- PPCB
- Sector
- MDCX
- PPCB
- Exchange
- MDCX Nasdaq
- PPCB Nasdaq
- Market Cap
- MDCX 36.2M
- PPCB 39.1M
- IPO Year
- MDCX N/A
- PPCB N/A
- Fundamental
- Price
- MDCX $1.94
- PPCB $3.02
- Analyst Decision
- MDCX Strong Buy
- PPCB
- Analyst Count
- MDCX 2
- PPCB 0
- Target Price
- MDCX $23.50
- PPCB N/A
- AVG Volume (30 Days)
- MDCX 408.7K
- PPCB 5.1M
- Earning Date
- MDCX 08-11-2025
- PPCB 09-30-2025
- Dividend Yield
- MDCX N/A
- PPCB N/A
- EPS Growth
- MDCX N/A
- PPCB N/A
- EPS
- MDCX N/A
- PPCB N/A
- Revenue
- MDCX N/A
- PPCB N/A
- Revenue This Year
- MDCX N/A
- PPCB N/A
- Revenue Next Year
- MDCX N/A
- PPCB N/A
- P/E Ratio
- MDCX N/A
- PPCB N/A
- Revenue Growth
- MDCX N/A
- PPCB N/A
- 52 Week Low
- MDCX $1.80
- PPCB $0.00
- 52 Week High
- MDCX $8.94
- PPCB $145.46
- Technical
- Relative Strength Index (RSI)
- MDCX 38.69
- PPCB N/A
- Support Level
- MDCX $1.88
- PPCB N/A
- Resistance Level
- MDCX $2.27
- PPCB N/A
- Average True Range (ATR)
- MDCX 0.26
- PPCB 0.00
- MACD
- MDCX 0.02
- PPCB 0.00
- Stochastic Oscillator
- MDCX 19.40
- PPCB 0.00
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.